This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Choosing between a stock index and an index fund depends on costs, flexibility, and your investment objectives. This article compares the options clearly.
25,679 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Microsoft stock remains volatile in mid-2026 as AI momentum collides with rising capex and a securities suit. Yet the...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
Constellation Energy will release its annual guidance in March, but its shares rose to a six-week high on Tuesday as ...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
Looking for the best-performing tech stocks this week? This guide breaks down how to spot momentum, what to watch, an...
NVIDIA riding robust AI demand, elevated data-center spending, and resilient margins as 2026 unfolds. Analysts weigh ...
As the power transition accelerates, two giants—American Electric Power and GE Vernova—offer very different routes fo...
As military spending climbs worldwide, select defense stocks poised benefit due to diversified portfolios, strong cas...
Roth IRAs are popular for tax-free growth, but they’re not the perfect fit for everyone. Here are three practical rea...
With $1,000 to invest, you’re at a crossroads: bet on XRP’s institutional plumbing or Zcash’s privacy-forward store o...
Lennar's latest results reveal a pricing move not seen in years. This article breaks down why lennar hasn't sold home...